IMMUNOPATHOLOGY AND BIOCHEMICAL VIEWPOINTS BEHIND THE TREATMENT OF ATOPIC CONDITIONS


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Investigations of altered immunological reactivity provide a key for understanding the atopic disease. Multisite receptor interactions of first-generation antihistamines like clemastine offer rapid therapeutic efficacy in allergology and pediatry ward.

全文:

受限制的访问

作者简介

I. Grigoryeva

Institute of Allergology and Clinical Immunology

A. Sergeyev

I.M. Sechenov First Moscow State Medical University

I. Manina

Institute of Allergology and Clinical Immunology

E. Kudryavtseva

Medico-C Medical Rehabilitation Center

Email: iaci@iaci.ru
Moscow

参考

  1. Сергеев Ю.В., Новиков Д.К., Караулов А.В. и др. Атопический дерматит: гетерогенность клинических форм и разнообразие механизмов патогенеза // Иммунопатология, аллергология, инфектология. - 2001; 3: 61-73.
  2. Noh G., Lee J. Revision of immunopathogenesis and laboratory interpretation for food allergy in atopic dermatitis // Inflamm. Allergy Drug. Targets. - 2012; 11 (1): 20-35.
  3. Proksch E., Weidinger S. New insights into the pathogenesis of sensitive skin // Hautarzt. - 2011; 62 (12): 900-905..
  4. Herman S., Vender R. Antihistamines in the treatment of dermatitis // Cutan Med Surg. - 2003; 7 (6): 467-473.
  5. Strid J., Sobolev O., Zafirova B. et al. The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy // Science. - 2011; 334 (6060): 1293-1297.
  6. Binder A., Koroschetz J., Baron R. Disease mechanisms in neuropathic itch // Nat. Clin. Pract. Neurol. - 2008; 4 (6): 329-337.
  7. Lee C., Yu H. Biomarkers for itch and disease severity in atopic dermatitis // Curr. Probl. Dermatol. - 2011; 41: 136-148.
  8. Sunyer J., Basagaña X., Gonzalez J. et al. Early life environment, neurodevelopment and the interrelation with atopy // Environ. Res. - 2010; 110 (7): 733-738.
  9. Ando T., Hashiro M., Noda K. et al. Development and validation of the psychosomatic scale for atopic dermatitis in adults // J. Dermatol. - 2006; 33 (7): 439-450.
  10. Meador K., Loring D., Ray P. et al. Role of cerebral lateralization in control of immune processes in humans // Ann. Neurol. - 2004; 55 (6): 840-844.
  11. Muñoz-Hoyos A., Espín-Quirantes C., Molina-Carballo A. et al. Neuroendocrine and circadian aspects (melatonin and beta-endorphin) of atopic dermatitis in the child // Pediatr. Allergy Immunol. - 2007; 18 (8): 679-686.
  12. Ikoma A., Fartasch M., Heyer G. et al. Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch // Neurology. - 2004; 62 (2): 212-217.
  13. Sinkus M., Wamboldt M., Barton A. The α7 nicotinic acetylcholine receptor and the acute stress response: maternal genotype determines offspring phenotype // Physiol. Behav. - 2011; 104 (2): 321-326.
  14. Peters J., Cohen S., Staudenmayer J. et al. Prenatal negative life events increases cord blood IgE: interactions with dust mite allergen and maternal atopy: Epidemiology and Genetics // Allergy. - 2012; 6. doi: 10.1111/ j.1398-9995.2012.02791.x.
  15. Lazewska D., Kiec-Kononowicz K. Azines as histamine H4 receptor antagonists // Front Biosci (Schol Ed). - 2012; 4: 967-987.
  16. Iking A., Grundmann S., Chatzigeorgakidis E. et al. Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients // J. Eur. Acad. Dermatol. Venereol. - 20125.oi: 10.1111/ j.1468-3083.2012.04481.x.
  17. Geng S., Gao Y., Yang J. et al. Potential role of store-operated Ca(2+) entry in Th(2) response induced by histamine in human monocyte-derived dendritic cells // Int. Immunopharmacol. - 2012; 12 (2): 358-367.
  18. del Rio R., Noubade R., Saligrama N. et al. Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system // J. Immunol. - 2012; 188 (2): 541-547.
  19. Liezmann C., Klapp B., Peters E. Stress, atopy and allergy: A re-evaluation from a psychoneuroimmunologic persepective // Dermatoendocrinol. - 2011; 3 (1): 37-40.
  20. Steinman L. Elaborate interactions between the immune and nervous systems // Nat. Immunol. - 2004; 5 (6): 575-581.
  21. Johansen P., Weiss A., Bünter A. et al. Clemastine causes immune suppression through inhibition of extracellular signal-regulated kinase-dependent proinflammatory cytokines // J. Allergy Clin. Immunol. - 2011; 128 (6): 1286-1294.
  22. Doherty V., Sylvester D., Kennedy C. et al. Treatment of itching in atopic eczema with antihistamines with a low sedative profile // BMJ. - 1987 (298): 96.
  23. Ito C. Histamine H3-receptor inverse agonists as novel antipsychotics // Cent Nerv Syst Agents Med Chem. - 2009; 9 (2): 132-136.
  24. Connelly W., Shenton F., Lethbridge N. et al. The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS // Br. J. Pharmacol. - 2009 May; 157 (1): 55-63.
  25. Johansen P., Weiss A., Bünter A. et al. Clemastine causes immune suppression through inhibition of extracellular signal-regulated kinase-dependent proinflammatory cytokines. // J Allergy Clin Immunol. - 2011; 128 (6): 1286-1294.
  26. Lojek A., Cíž M., Pekarová M.et al. Modulation of metabolic activity of phagocytes by antihistamines // Interdiscip Toxicol. - 2011; 4 (1): 15-19.
  27. Lindsberg P., Strbian D., Karjalainen-Lindsberg M. et al. Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage // J. Cereb. Blood. Flow. Metab. - 2010; 30 (4): 689-702.
  28. Chung J., deTineo M., Naclerio R. et al. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction // Annals of allergy, asthma & immunology. - 1997 (78): 307-312.
  29. Dorckhorn R., Bergner A., Connell J. et al. Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis // Ann. Allergy. - 1987; 58: 407-411.
  30. Frolund L., Etholm B., Irlander K. et al. A multicentre study of loratadine, clemastine and placebo in patients with perennial allergic rhinitis // Allergy. - 1990; 45: 254-261.
  31. Лусс Л.В. Выбор антигистаминных препаратов в лечении аллергических и псевдоаллергических реакций // Рос. аллергологический журнал. - 2009; 1: 1-7.
  32. Полосьянц О.Б. Обзор антигистаминных средств первого и второго поколений, рациональный подход к использованию в клинической практике // Лечащий врач. - 2001; 7.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2012